BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 25, 2008
View Archived Issues
Recent Wonkisopharm patent reports novel therapeutic option for skin hyperpigmentation
Read More
Novel analgesic agents disclosed in recent patent literature
Read More
New therapeutic agents for neurological disorders reported in recent patents
Read More
Targeting the PI3K/Akt pathway beneficial against HIV infection
Read More
Positive preclinical results with staphylococcal enterotoxin B vaccine (STEBVax)
Read More
Acceleron and Celgene enter collaboration for ACE-011 cancer-related bone loss
Read More
Avexa initiates first test site for phase III trial of apricitabine for HIV
Read More
Sequenom reports encouraging results with noninvasive prenatal test for Down's syndrome
Read More
AGI Therapeutics reports key findings from pharmacokinetic study of Rezular
Read More
Sirtris enters agreement with the National Cancer Institute to test SIRT1 enzyme activators
Read More
Novel 5-HT6 receptor antagonist potentially useful as cognition enhancer
Read More
Allon Therapeutics adds Alzheimer's patients to ongoing phase II clinical trial of AL-108
Read More
PharmaIN received grant of USD 400,000 from the NIH for PGC-lysostaphin
Read More
Adherex receives FDA orphan drug designation for ADH-1 in melanoma
Read More
EMEA recommends marketing authorization of Ipsen's Adenuric
Read More
FDA grants priority review for prasugrel in acute coronary syndrome
Read More
ImClone Systems enrolls first patient in disease-directed phase II IMC-1121B trial
Read More
Sosei initiates a phase III trial for NorLevo
Read More
New oncolytic virus shows activity against brain and peripheral tumors
Read More
GSK receives CHMP positive opinion for Volibris
Read More
FDA to accelerate approval of Avastin plus paclitaxel as first-line breast cancer therapy
Read More
BioAlliance to acquire Immtech products despite pafuramidine program discontinuation
Read More
FDA approves Abbott's Humira for polyarticular juvenile idiopathic arthritis
Read More
